Position in CDNA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$72,475
+$29,232 QoQ
Shares Held
2,543
+2.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#178
of 225 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $27,749,084 across 35 Diagnostics & Research names. CDNA ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,334 | $12,200,093 | |
| 2 | A |
Agilent Technologies, Inc.
|
20,420 | $2,712,388 | |
| 3 | DHR |
Danaher Corp /De/
|
11,176 | $2,128,804 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
3,894 | $2,062,223 | |
| 5 | LH |
Labcorp Holdings Inc.
|
5,963 | $1,669,640 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
2,531 | $1,332,419 | |
| 7 | NTRA |
Natera, Inc.
|
3,878 | $1,052,683 | |
| 8 | ILMN |
Illumina, Inc.
|
5,976 | $1,050,760 |
All Filings in CDNA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,475 | 2,543 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $43,243 | 2,491 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,659 | 2,052 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $29,458 | 2,026 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $40,057 | 2,050 | Shares | Sole | 2025-08-07 | |
| 2023-03-31 | $831 | 91 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $684 | 60 | Shares | Sole | 2023-01-13 | |
| 2022-06-30 | $107 | 5 | Shares | Sole | 2022-07-13 | |
| 2020-06-30 | $15,943 | 450 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $9,823 | 450 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||